IPO registrations (S-1, F-1) · Registrants
GeneDx Holdings Corp.
- SEC CIK
- 1818331 · filings on EDGAR ↗
- Name on the registration
- Sema4 Holdings Corp.
- Former names
- Sema4 Holdings Corp. (2021–2023); CM Life Sciences, Inc. (2020–2021)
- Registration
- Form S-1, first filed 2020-08-14, last 2022-05-03; 3 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2020-09-03; declared effective 2020-09-01
- Industry (SIC)
- Services-Health Services 8000
- Incorporated in
- DE
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, Stamford, CT 06902
- EIN
- 85-1966622
- Ticker
- WGS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- GeneDx Holdings Corp. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-09-03, an initial public offering)
- Listing
- Nasdaq under the symbol CMLF
- Lead underwriters
- Jefferies (38,500,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: GENEDX HOLDINGS CORP. Fuzzy (name and state)
- Business registration: GENEDX HOLDINGS CORP. Fuzzy (name and state)
- Form 5500 plan sponsor: GENEDX HOLDINGS CORP. EXACT (EIN (EXACT))
- SEC filer: CM Life Sciences, Inc. EXACT (CIK (EXACT))
- Person page: Richard C Pfenniger Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-08-14 | S-1 | S-1 (registration) | CM Life Sciences, Inc. | 0001213900-20-022185 ↗ |
| 2020-08-24 | S-1/A | S-1/A (amendment) | CM Life Sciences, Inc. | 0001213900-20-023383 ↗ |
| 2020-08-27 | S-1/A | S-1/A (amendment) | CM Life Sciences, Inc. | 0001213900-20-023960 ↗ |
| 2020-09-01 | S-1MEF | S-1MEF (added securities) | CM Life Sciences, Inc. | 0001213900-20-024904 ↗ |
| 2020-09-01 | EFFECT | EFFECT (declared effective) | CM Life Sciences, Inc. | 9999999995-20-002331 ↗ |
| 2020-09-03 | 424B4 | 424B4 (final prospectus) | CM Life Sciences, Inc. | 0001213900-20-025225 ↗ |
| 2021-08-04 | S-1 | S-1 (registration) | Sema4 Holdings Corp. | 0001628280-21-015606 ↗ |
| 2021-08-12 | EFFECT | EFFECT (declared effective) | Sema4 Holdings Corp. | 9999999995-21-003194 ↗ |
| 2022-03-24 | EFFECT | EFFECT (declared effective) | Sema4 Holdings Corp. | 9999999995-22-000710 ↗ |
| 2022-05-03 | S-1 | S-1 (registration) | Sema4 Holdings Corp. | 0001628280-22-011819 ↗ |
| 2022-05-11 | EFFECT | EFFECT (declared effective) | Sema4 Holdings Corp. | 9999999995-22-001422 ↗ |
| 2022-09-07 | EFFECT | EFFECT (declared effective) | Sema4 Holdings Corp. | 9999999995-22-002612 ↗ |
| 2022-09-07 | EFFECT | EFFECT (declared effective) | Sema4 Holdings Corp. | 9999999995-22-002613 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-08-24 | S-1/A | registration statement | $10.00 | 35,000,000 | $350,000,000 | Nasdaq CMLF | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2020-08-27 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2020-09-03 | 424B4 | final prospectus | $10.00 | - | - | Nasdaq CMLF | 1 | primary document; price sentence, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Casdin Eli | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer | 25 | 2020–2026 | |
| C-LSH LLC | TenPercentOwner | 1 | 2020 | ||
| CMLS Holdings LLC | TenPercentOwner | 1 | 2020 | ||
| Emes Brian | Officer | CFO and Secretary | 1 | 2020 | |
| George Sean E | Director | 1 | 2020 | ||
| Islam Munib | Director | 1 | 2020 | ||
| Leproust Emily M. | Director | 12 | 2020–2026 | ||
| Meister Keith A. | Director; Director,TenPercentOwner | 22 | 2020–2026 | ||
| M-LSH LLC | TenPercentOwner | 1 | 2020 | ||
| Rodriguez Shaun | Officer | Chief Strategy Officer | 1 | 2020 | |
| Turner Nat | Director | 4 | 2020–2022 | ||
| Assad Shawn | Officer; Other | Chief Accounting Officer | 11 | 2021–2023 | |
| Charney Dennis | Director | 2 | 2021 | ||
| Clark Daniel Emmett | Officer; Other | Secretary and General Counsel | 15 | 2021–2023 | |
| Coffin James | Officer | President and COO | 6 | 2021 | |
| Pellini Michael J | Director | 6 | 2021–2022 | ||
| Prentice Anthony | Officer; Other | Chief Product Officer | 13 | 2021–2023 | |
| Ro Isaac | Officer; Other | Chief Financial Officer; Former CFO | 13 | 2021–2023 | |
| RUCH JOSHUA | Director | 20 | 2021–2026 | ||
| Ryan Jason | Director; Director,Officer | Executive Chairman | 19 | 2021–2026 | |
| Saad Kareem | Officer | Chief Business Officer; Chief Transformation Officer; CHIEF TRANSFORMATION OFFICER | 37 | 2021–2024 | |
| Schadt Eric | Director,Officer | Chief Executive Officer; President & Chief R&D Officer | 12 | 2021–2022 | |
| Sherman Rachel E. | Director | 8 | 2021–2023 | ||
| White Karen Ann | Officer | Chief People Officer | 26 | 2021–2023 | |
| Blackstone Alternative Solutions L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Group Management L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings I/II GP L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings III GP L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings III GP Management L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings III L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings II L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Holdings I L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Inc | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Tactical Opportunities Associates III - NQ L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Tactical Opportunities Associates L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| Blackstone Tactical Opportunities Fund - FD L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| BTOA L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| BTO DE GP - NQ L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| BTO Holdings Manager L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| BTO Sema4 Holdings L.P. | TenPercentOwner | 2 | 2021–2022 | ||
| BTO Side-by-Side GP L.L.C. | TenPercentOwner | 2 | 2021–2022 | ||
| SCHWARZMAN STEPHEN A | TenPercentOwner | 2 | 2021–2022 | ||
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | TenPercentOwner | 5 | 2021–2024 | ||
| MOUNT SINAI HEALTH SYSTEM, INC. | TenPercentOwner | 5 | 2021–2024 | ||
| PFENNIGER RICHARD C JR | Director | 14 | 2022–2026 | person page Fuzzy | |
| Stueland Katherine | Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 58 | 2022–2026 | |
| OPKO HEALTH, INC. | TenPercentOwner | 13 | 2022–2024 | ||
| Miao Richard | Officer; Other | Interim CFO | 3 | 2022–2023 | |
| Feeley Kevin | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 74 | 2022–2026 | |
| Corvex Management LP | Director,TenPercentOwner; TenPercentOwner | 10 | 2023–2026 | ||
| Casdin Capital, LLC | Director,TenPercentOwner | 11 | 2023–2026 | ||
| Casdin Partners FO1-MSV, LP | Director; Director,TenPercentOwner; TenPercentOwner | 6 | 2023–2024 | ||
| Casdin Partners GP, LLC | Director,TenPercentOwner | 11 | 2023–2026 | ||
| Casdin Partners Master Fund, L.P. | Director,TenPercentOwner | 11 | 2023–2026 | ||
| Dechairo Bryan | Officer | Chief Operating Officer | 5 | 2025–2026 | |
| Fuchs Thomas | Director | 4 | 2025–2026 | ||
| GARDNER MARK A | Officer | President | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | GENEDX HOLDINGS CORP. | CT | State business registries | name and state |
| Business registration | GENEDX HOLDINGS CORP. | CT | State business registries | name and state |
| SEC filer | GeneDx Holdings Corp. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | GeneDx Holdings Corp. | CT | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | GENEDX HOLDINGS CORP. | EIN (EXACT) | ||
| Person page | Richard C Pfenniger Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.